Table.

Characteristics of patients with SLE at baseline.

Up to Date,
n = 76
Not Up to Date,
n = 66
P
Sociodemographics
    Age, yrs, median (IQR)43.0 (37.7-50.0)43.0 (33.0-51.0)0.47
    Healthcare insurance58 (76)49 (74)0.85
    Profession
        Senior executive11 (14)8 (12)0.81
        Intermediate occupation30 (39)12 (18)0.01
        Employee/worker8 (10)2 (3)0.11
        Student0 (0)2 (3)0.21
        Retired1 (1)0 (0)> 0.99
        Unemployed14 (18)26 (39)0.01
SLE disease characteristicsa
    SLE duration, yrs, median (IQR)12.0 (5.0-22.0)8.5 (4.0-16.2)0.12
    Arthritis55 (72)45 (68)0.71
    Skin lesions48 (63)40 (61)0.86
    Class III/IV/V LN30 (39)25 (38)0.86
    SLEDAI, median (IQR)2 (0-4)2 (0-4)0.85
    Current prescription of HCQ67 (82)60 (91)0.78
    Current prescription of steroids39 (51)29 (44)0.40
    Current prescription of IS drugs23 (30)17 (26)0.58
Sexual and behavior risk factors
    Lifetime sexual partners, median (IQR)2.5 (1.0-4.0)3.0 (1.0-5.0)0.63
    Age at sexual debut, yrs, median (IQR)19.0 (17.0-22.5)19.0 (17.5-20.5)0.99
    Previous STD5 (7)1 (1)0.22
    Previous/current use of hormonal contraception48 (63)34 (51)0.18
    HPV vaccine3 (4)1 (1)0.62
    Ever/current smoking14 (18)10 (15)0.66
    Multiparity30 (39)19 (29)0.22
Knowledge about CCS
    CCS is performed for the diagnosis of:
            Infection47 (62)30 (45)0.06
            Malignancy51 (67)39 (59)0.38
            SLE-specific features5 (7)12 (18)0.04
Reasons for not being up to date for CCS
    Not knowing my GPs could perform CCS24 (36)
    Not knowing CCS should be repeated, even when normal at first20 (30)
    CCS is unpleasant/painful19 (29)
    Postponed17 (26)
    Cannot get a gynecologist where I live14 (21)
    Not being advised by my GP/specialist to have CCS12 (18)
    No reason because no hormonal contraception10 (15)
    Too many physicians’ appointments8 (12)
    No reason because no sexual relationship6 (9)
    Cost5 (8)
    Not feeling able to send sample to a laboratory for analysis2 (3)
  • Values are expressed as n (%) unless indicated otherwise.

  • a The median time delay between SLE disease assessment and CCS in patients who were not up to date at baseline was 2.5 (range 0.5-8.0) months. CCS: cervical cancer screening; GP: general practitioner; HCQ: hydroxychloroquine; HPV: human papillomavirus; IS: immunosuppressive; LN: lupus nephritis; SLE: systemic lupus erythematosus; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; STD: sexually transmitted disease.